Should I Buy BUSE? BUSE 2026 Analysis

Should You Buy First Busey Corp (BUSE) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

27.270

1 Day change

2.83%

52 Week Range

27.340

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Buy now: Trend and momentum are bullish (MACD expanding, bullish MA stack), options positioning is strongly call-leaning, and Wall Street just raised targets.
Near-term upside levels: price is already above R1 (26.253) with room toward R2 ~26.861 and the latest Street target $29 as the next logical upside magnet.
Why not wait: despite being a bit extended short-term, there are no bearish flow or fundamental red flags in the provided data.

Intellectia Proprietary Trading Signals

AI Stock Picker: No signal on given stock today.
SwingMax: No signal on given stock recently.

Technical Analysis

Trend: Bullish; moving averages are stacked SMA_5 > SMA_20 > SMA_200, confirming an established uptrend.
Momentum: MACD histogram +0.135 and expanding → momentum is strengthening.
Overbought/extension: RSI_6 = 75.547 → price is extended short-term (more prone to pauses than immediate acceleration).
Key levels:
- Pivot: 25.269 (first area to watch for dip support)
- Support: S1 24.286
- Resistance: R2 26.861 (next upside checkpoint)
Pattern-based odds (provided): biased upward over 1W–1M (next week +3.62%, next month +10.87% expectation in the pattern set).

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning: Open interest put/call 0.19 = heavily call-skewed (bullish sentiment/positioning).
Volume: Very light (total volume 5; puts 0) → sentiment is bullish, but signal quality is limited by low liquidity.
Implied volatility: IV30 36.36 vs HV 29.72 (options pricing in moderate premium), but IV rank 13.15 / percentile 18.73 suggests IV is low relative to its own history (options not “expensive” vs recent range).
Today vs average activity: volume is elevated vs its 30D average (41.67), but from a small base.

Technical Summary

Sell

Buy

Positive Catalysts

- Analyst support improving: Piper Sandler raised PT to $29 (from $26) and reiterated Overweight.
- Strong reported growth (latest quarter): 2025/Q4 showed large YoY increases in revenue, net income, and EPS.
- Technical momentum: positive, expanding MACD and bullish MA structure.
- Options sentiment: strong call skew (very low put/call OI ratio).

Neutral/Negative Catalysts

- Short-term stretched: RSI_6 above 75 increases odds of a near-term pause/consolidation.
- Near resistance: price is already near the 26.86 area (R2), which can slow upside.
- Low options liquidity: extremely low volume/open interest can make options-based sentiment less reliable.
- No fresh news catalysts: “No news in recent week” reduces odds of an immediate event-driven breakout.

Financial Performance

Latest quarter: 2025/Q4
Revenue: 176,928,000 (+76.37% YoY) → strong top-line expansion.
Net income: 56,160,000 (+99.82% YoY) → profitability ramped sharply.
EPS: 0.63 (+28.57% YoY) → solid per-share growth.
Overall read: growth trends are clearly positive in the latest reported quarter based on provided figures.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

2026-01-30 (Piper Sandler): raised price target to $29 from $26, maintained Overweight.
Wall Street pro view (pros): improving target/support and confidence in leadership continuity post-executive change.
Wall Street con view (cons): leadership transition risk is acknowledged (even if viewed as manageable); no additional analyst confirmations provided beyond this update.

3 Analyst Rating

Wall Street analysts forecast BUSE stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BUSE is 26.33 USD with a low forecast of 24 USD and a high forecast of 29 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

1 Hold

0 Sell

Moderate Buy

Current: 26.520

Low

Averages

26.33

High

Current: 26.520

Low

Averages

26.33

High

Piper Sandler

Overweight

maintain

$26 -> $29

AI Analysis

2026-01-30

Reason

Piper Sandler

Price Target

$26 -> $29

AI Analysis

2026-01-30

maintain

Overweight

Reason

Piper Sandler raised the firm's price target on First Busey to $29 from $26 and keeps an Overweight rating on the shares. The firm says that while former President Mike Maddox's recent exit is not entirely surprising given the CFB merger's structuring and among other factors, Piper is highly optimistic that production-related continuity will be maintained under recently promoted bank President Tony Hammond and Chairman, President & CEO Dukeman's extended leadership position.

Piper Sandler

Overweight

downgrade

$30 -> $26

2025-10-31

Reason

Piper Sandler

Price Target

$30 -> $26

2025-10-31

downgrade

Overweight

Reason

Piper Sandler lowered the firm's price target on First Busey to $26 from $30 and keeps an Overweight rating on the shares. Apart from shrinkage in both loans and core deposits, First Busev posted solid Q3 results as PPNR was within 1% of expectations and aided by greater net interest margin expansion, the firm says. Piper remains bullish with First Busev well-positioned for multiple expansion closer to peers via a likely rebound to low-to-mid-single digit loan and core deposit growth as well as with strong core fee income increases.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BUSE

Unlock Now

BUSE Should I Buy

BUSE Should I Buy

Should You Buy First Busey Corp (BUSE) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch